Español
|
English
BUSCADOR
CIBER
INTRANET
LINKS
WEBMAIL
Toggle navigation
MENÚ
About Us
Welcome from the Scientific Director
Mission and Objectives
Structure
Steering Committee
External Scientific Advisory Committee (ESAC)
Governing Board
Permanent Commission
Consortium Institutions
Head Office
Thematic Areas
Information Resources
Contact
Groups
Research Groups
Clinical Linked Groups
Geographical Distribution
Research Programmes
Chronic Respiratory Diseases
Obstructive Sleep Apnea
Asthma
Lung Cancer
Chronic Obstructive Pulmonary Disease (COPD)
Infectious Respiratory Diseases
Host-Pathogen Interactions
Pneumonia
Tuberculosis
Singular Respiratory Diseases
Pulmonary Fibrosis
Pulmonary Hypertension
Acute Lung Injury (ALI)
Transversal Programmes
Internationalization Programme
Training Programme
Technology offer and know how
Technology Offer
Platforms
Pulmonary Biobank Consortium
Press
Events
CIBER Newsletter
CIBERES Newsletter
Previous Newsletter
Sala de Prensa
Agenda
EL PAPEL DE ESPAÑA EN LA I+D DE NUEVAS VACUNAS CONTRA LA TUBERCULOSIS
EL PAPEL DE ESPAÑA EN LA I+D DE NUEVAS VACUNAS CONTRA LA TUBERCULOSIS
From Tuesday, March 28, 2023 to Tuesday, March 28, 2023
Programa:
Descargar.
Back to List
